1. CCL2 serves as a downstream effector of interleukin‐1β and tumour necrosis factor‐α signalling in Schnitzler syndrome. (1st April 2019) Authors: Kambe, N.; Nguyen, C. T. H. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗